ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

5 links0 made here, not in the record10 judgments2 judges (our rules as one)0 record changes seen
Claude Opus 5.5Our rules
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07282509Safety and Efficacy ofPaclitaxel LiposomeArterial Infusion CombinedWith Systemic Therapy forSecond-Line Treatment ofAdvanced Liver CancerCSPC ZhongQi Pharmaceutical TePhase 1/Phase 2 · not yet recrRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, HepatocellularNo longer in the registry's filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSINT024362Entry “HA131”, read by our name rule›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Our role rule · TestedTestedEnlonstobartEntry “Enlonstobart Injection”, read …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Our role rule · TestedBackgroundPembrolizumabEntry “Pembrolizumab Injection”, read…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Our role rule · BackgroundBackgroundLenvatinibEntry “Lenvatinib Mesilate Capsules”,…›Nov 2 · Claude Opus 5.5 · Background · partnerNov 18 · Our role rule · BackgroundBackground · partner

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

INT024362

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “HA131”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2INT024362Claude Opus 5.5TestedCurrent
Nov 2EnlonstobartClaude Opus 5.5BackgroundCurrent
Nov 2PembrolizumabClaude Opus 5.5BackgroundCurrent
Nov 2LenvatinibClaude Opus 5.5Background · partnerCurrent
Nov 14Carcinoma, HepatocellularOur condition-kind ruleFinest filed termCurrent
Nov 18INT024362Our role ruleTestedAgrees
Nov 18EnlonstobartOur role ruleTestedOverridden
Nov 18PembrolizumabOur role ruleBackgroundAgrees
Nov 18LenvatinibOur role ruleBackgroundAgrees
As of nowCarcinoma, HepatocellularOur main-condition rule (R9)Main conditionCurrent